cholestanones - CISMeF

Preferred Label : cholestanones;

MeSH definition : CHOLESTANES substituted with any number of keto groups.;

MeSH annotation : do not confuse with CHOLESTENONES; includes cholestanediones, cholestanetriones;

Is substance : O;

Détails

Origin ID

D002778;

UMLS CUI

C0008369;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- cholestanones [MeSH concept]
Related MeSH Supplementary Concept(s)
- (20R)-3beta,20,26-trihydroxy-27-norcholest-5-en-22-one [MeSH Supplementary Concept]
- (23R,25S)-3beta-acetoxy-16beta,23:23,26-diepoxy-5beta-cholestan-22-one [MeSH Supplementary Concept]
- 16,20-dihydroxycholestan-3-one [MeSH Supplementary Concept]
- 16,23-oxidoalisol B [MeSH Supplementary Concept]
- 16-hydroxycholestane-3,6-dione [MeSH Supplementary Concept]
- 2,3-dihydroxycholestan-6-one [MeSH Supplementary Concept]
- 2-carbomethoxy-A-nor-5 alpha-cholestan-3-one [MeSH Supplementary Concept]
- 20-hydroxycholest-1-en-3,16-dione [MeSH Supplementary Concept]
- 20-hydroxycholestane-3,16-dione [MeSH Supplementary Concept]
- 27-nor-3,7,12-trihydrocoprostan-24-one [MeSH Supplementary Concept]
- 3 beta-acetoxy-8 alpha,14 alpha-epoxy-5 alpha-cholestan-7-one [MeSH Supplementary Concept]
- 3-Epi-6,7-dideoxyxestobergsterol A [MeSH Supplementary Concept]
- 3-bromo-5,22,23-trihydroxystigmastan-6-one [MeSH Supplementary Concept]
- 3-hydroxy-5,6-epoxy-9-oxo-9,10-seco-5-cholest-7-en-11-al [MeSH Supplementary Concept]
- 3-hydroxy-5-cholestan-15-one [MeSH Supplementary Concept]
- 3-hydroxy-5-oxo-5,6-secocholestan-6-al [MeSH Supplementary Concept]
- 3beta-hydroxy-5beta-cholestan-6-one [MeSH Supplementary Concept]
- 7 alpha,12 alpha,26-trihydroxy-5 beta-cholestan-3-one [MeSH Supplementary Concept]
- 7 alpha,12 alpha-dihydroxy-3-oxo-5 beta-cholestan-26-al [MeSH Supplementary Concept]
- butenandt's dihydroacid [MeSH Supplementary Concept]
- cholestane-3,6-dione [MeSH Supplementary Concept]
- hipposterone N [MeSH Supplementary Concept]
- homobrassinolide [MeSH Supplementary Concept]
- homocastasterone [MeSH Supplementary Concept]
- thunberol [MeSH Supplementary Concept]
- xestobergsterol A [MeSH Supplementary Concept]
- xestobergsterol B [MeSH Supplementary Concept]
- xestobergsterol C [MeSH Supplementary Concept]
- yakkasterone [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients